These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 20110302)

  • 1. Interaction of herpes simplex virus type 2 (HSV-2) glycoprotein D with the host cell surface is sufficient to induce Chlamydia trachomatis persistence.
    Vanover J; Kintner J; Whittimore J; Schoborg RV
    Microbiology (Reading); 2010 May; 156(Pt 5):1294-1302. PubMed ID: 20110302
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An early event in the herpes simplex virus type-2 replication cycle is sufficient to induce Chlamydia trachomatis persistence.
    Deka S; Vanover J; Sun J; Kintner J; Whittimore J; Schoborg RV
    Cell Microbiol; 2007 Mar; 9(3):725-37. PubMed ID: 17140408
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chlamydia trachomatis enters a viable but non-cultivable (persistent) state within herpes simplex virus type 2 (HSV-2) co-infected host cells.
    Deka S; Vanover J; Dessus-Babus S; Whittimore J; Howett MK; Wyrick PB; Schoborg RV
    Cell Microbiol; 2006 Jan; 8(1):149-62. PubMed ID: 16367874
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Herpes simplex virus co-infection-induced Chlamydia trachomatis persistence is not mediated by any known persistence inducer or anti-chlamydial pathway.
    Vanover J; Sun J; Deka S; Kintner J; Duffourc MM; Schoborg RV
    Microbiology (Reading); 2008 Mar; 154(Pt 3):971-978. PubMed ID: 18310043
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Host nectin-1 is required for efficient Chlamydia trachomatis serovar E development.
    Hall JV; Sun J; Slade J; Kintner J; Bambino M; Whittimore J; Schoborg RV
    Front Cell Infect Microbiol; 2014; 4():158. PubMed ID: 25414835
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chlamydial Pre-Infection Protects from Subsequent Herpes Simplex Virus-2 Challenge in a Murine Vaginal Super-Infection Model.
    Slade J; Hall JV; Kintner J; Schoborg RV
    PLoS One; 2016; 11(1):e0146186. PubMed ID: 26726882
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Mechanisms of Chlamydia trachomatis and herpes simplex virus persistence during viral-bacterial infection].
    Bekhalo VA; Sysoliatina EV; Nagurskaia EV
    Zh Mikrobiol Epidemiol Immunobiol; 2009; (5):105-10. PubMed ID: 20066779
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro study of a double infection by herpes simplex virus type 2 and Chlamydia trachomatis.
    Chiarini F; Mansi A; Pisani S; Seganti L; Brunori S; Gentile V; Di Silverio F
    New Microbiol; 1996 Jul; 19(3):263-6. PubMed ID: 8841043
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Imbalanced oxidative stress causes chlamydial persistence during non-productive human herpes virus co-infection.
    Prusty BK; Böhme L; Bergmann B; Siegl C; Krause E; Mehlitz A; Rudel T
    PLoS One; 2012; 7(10):e47427. PubMed ID: 23077614
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prophylactic Herpes Simplex Virus 2 (HSV-2) Vaccines Adjuvanted with Stable Emulsion and Toll-Like Receptor 9 Agonist Induce a Robust HSV-2-Specific Cell-Mediated Immune Response, Protect against Symptomatic Disease, and Reduce the Latent Viral Reservoir.
    Hensel MT; Marshall JD; Dorwart MR; Heeke DS; Rao E; Tummala P; Yu L; Cohen GH; Eisenberg RJ; Sloan DD
    J Virol; 2017 May; 91(9):. PubMed ID: 28228587
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Porcine epidemic diarrhea virus (PEDV) co-infection induced chlamydial persistence/stress does not require viral replication.
    Schoborg RV; Borel N
    Front Cell Infect Microbiol; 2014; 4():20. PubMed ID: 24660163
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of sustained antibiotic bactericidal treatment on Chlamydia trachomatis-infected epithelial-like cells (HeLa) and monocyte-like cells (THP-1 and U-937).
    Mpiga P; Ravaoarinoro M
    Int J Antimicrob Agents; 2006 Apr; 27(4):316-24. PubMed ID: 16527461
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chlamydia trachomatis persistence in vitro: an overview.
    Wyrick PB
    J Infect Dis; 2010 Jun; 201 Suppl 2(Suppl 2):S88-95. PubMed ID: 20470046
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mutations in the N termini of herpes simplex virus type 1 and 2 gDs alter functional interactions with the entry/fusion receptors HVEM, nectin-2, and 3-O-sulfated heparan sulfate but not with nectin-1.
    Yoon M; Zago A; Shukla D; Spear PG
    J Virol; 2003 Sep; 77(17):9221-31. PubMed ID: 12915538
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Herpes Simplex Virus 2 (HSV-2) gD Mutant Impaired for Neural Tropism Is Superior to an HSV-2 gD Subunit Vaccine To Protect Animals from Challenge with HSV-2.
    Wang K; Goodman KN; Li DY; Raffeld M; Chavez M; Cohen JI
    J Virol; 2016 Jan; 90(1):562-74. PubMed ID: 26559846
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Commonly prescribed β-lactam antibiotics induce C. trachomatis persistence/stress in culture at physiologically relevant concentrations.
    Kintner J; Lajoie D; Hall J; Whittimore J; Schoborg RV
    Front Cell Infect Microbiol; 2014; 4():44. PubMed ID: 24783061
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel glycoprotein D-specific monoclonal antibody neutralizes herpes simplex virus.
    Du R; Wang L; Xu H; Wang Z; Zhang T; Wang M; Ning Y; Deng F; Hu Z; Wang H; Li Y
    Antiviral Res; 2017 Nov; 147():131-141. PubMed ID: 29061442
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of vaginal lactobacilli in Chlamydia trachomatis infection.
    Mastromarino P; Di Pietro M; Schiavoni G; Nardis C; Gentile M; Sessa R
    Int J Med Microbiol; 2014 Jul; 304(5-6):654-61. PubMed ID: 24875405
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chlamydia trachomatis and herpes simplex virus 2 infection in vulvar intraepithelial neoplasia associated with human papillomavirus.
    Kwaśniewska A; Korobowicz E; Visconti J; Zdunek M; Szymańiski M; Goździcka-Józefiak A
    Eur J Gynaecol Oncol; 2006; 27(4):405-8. PubMed ID: 17009637
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Damage/Danger Associated Molecular Patterns (DAMPs) Modulate Chlamydia pecorum and C. trachomatis Serovar E Inclusion Development In Vitro.
    Leonard CA; Schoborg RV; Borel N
    PLoS One; 2015; 10(8):e0134943. PubMed ID: 26248286
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.